Year in review 2012: Critical Care - respiratory infections

Critical Care

Volumn 17, Issue 6, 2013, Pages

  Nair, Girish B ^a   Niederman, Michael S ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ATRIAL NATRIURETIC FACTOR; BETA LACTAM; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CIPROFLOXACIN; CISATRACURIUM; CLINDAMYCIN; CORTICOSTEROID; DORIPENEM; IMIPENEM; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LINEZOLID; MACROLIDE; MEROPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; PROCALCITONIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; RIFAMPICIN; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BIOFILM; COMMUNITY ACQUIRED PNEUMONIA; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; ENDOTRACHEAL TUBE; HAEMOPHILUS INFLUENZAE; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LEGIONELLA PNEUMOPHILA; LUNG MYCOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIDRUG RESISTANCE; MYCOPLASMA PNEUMONIAE; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PNEUMONIA; PREVENTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; STRATIFICATION; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA; VIRUS; VIRUS PNEUMONIA; ADVERSE EFFECTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG EFFECTS; MECHANICAL VENTILATOR; MICROBIOLOGY; ORGANIZATION AND MANAGEMENT; PROCEDURES; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; STANDARDS; TRENDS;

ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; HOSPITAL MORTALITY; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; PNEUMONIA; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; VENTILATORS, MECHANICAL;

EID: 84892557543     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12773     Document Type: Review

References (54)

1. Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, Craven DE, Roberts PR, Arroliga AC, Hubmayr RD, Restrepo MI, Auger WR, Schinner R, Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, Craven DE, Roberts PR, Arroliga AC, Hubmayr RD, Restrepo MI, Auger WR, Schinner R. NASCENT Investigation Group, NASCENT Investigation Group Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008, 300:805-813. 10.1001/jama.300.7.805, 18714060, NASCENT Investigation Group, NASCENT Investigation Group.
2. Gil-Perotin S, Ramirez P, Marti V, Sahuquillo JM, Gonzalez E, Calleja I, Menendez R, Bonastre J. Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept. Crit Care 2012, 16:R93. 10.1186/cc11357, 3580639, 22621676.
3. Freestone PP, Hirst RA, Sandrini SM, Sharaff F, Fry H, Hyman S, O'Callaghan C. Pseudomonas aeruginosa-catecholamine inotrope interactions: a contributory factor in the development of ventilator-associated pneumonia?. Chest 2012, 142:1200-1210. 10.1378/chest.11-2614, 22556319.
4. Jendeberg AL, Stralin K, Hultgren O. Antimicrobial peptide plasma concentrations in patients with community-acquired pneumonia. Scand J Infect Dis 2013, 45:432-437. 10.3109/00365548.2012.760844, 23317166.
5. Nguyen EV, Gharib SA, Palazzo SJ, Chow YH, Goodlett DR, Schnapp LM. Proteomic profiling of bronchoalveolar lavage fluid in critically ill patients with ventilator-associated pneumonia. PloS One 2013, 8:e58782. 10.1371/journal.pone.0058782, 3591362, 23505561.
6. Xiao D, Zhao F, Lv M, Zhang H, Zhang Y, Huang H, Su P, Zhang Z, Zhang J. Rapid identification of microorganisms isolated from throat swab specimens of community-acquired pneumonia patients by two MALDI-TOF MS systems. Diagn Microbiol Infect Dis 2012, 73:301-307. 10.1016/j.diagmicrobio.2012.04.004, 22633336.
7. Menendez R, Sahuquillo-Arce JM, Reyes S, Martinez R, Polverino E, Cilloniz C, Cordoba JG, Montull B, Torres A. Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia. Chest 2012, 141:1537-1545. 10.1378/chest.11-1446, 22194589.
8. Nowak A, Breidthardt T, Christ-Crain M, Bingisser R, Meune C, Tanglay Y, Heinisch C, Reiter M, Drexler B, Arenja N, Twerenbold R, Stolz D, Tamm M, Müller B, Müller C. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia. Chest 2012, 141:974-982. 10.1378/chest.11-0824, 22135381.
9. Wang F, Wu Y, Tang L, Zhu W, Chen F, Xu T, Bo L, Li J, Deng X. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis. Crit Care 2012, 16:R74. 10.1186/cc11331, 3580616, 22559153.
10. Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, Periat P, Bucher HC, Christ-Crain M. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008, 168:2000-2007. 10.1001/archinte.168.18.2000, 18852401.
11. Ramirez P, Ferrer M, Marti V, Reyes S, Martinez R, Menendez R, Ewig S, Torres A. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia. Crit Care Med 2011, 39:2211-2217. 10.1097/CCM.0b013e3182257445, 21705887.
12. Heyland DK, Johnson AP, Reynolds SC, Muscedere J. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit Care Med 2011, 39:1792-1799. 10.1097/CCM.0b013e31821201a5, 21358400.
13. Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Mueller B. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 2012, 55:651-662. 10.1093/cid/cis464, 3412690, 22573847.
14. Prina E, Ferrer M, Ranzani OT, Polverino E, Cillóniz C, Moreno E, Mensa J, Montull B, Menéndez R, Cosentini R, Torres A. Thrombocytosis is a marker of poor outcome in community-acquired pneumonia. Chest 2013, 143:767-775. 10.1378/chest.12-1235, 23187959.
15. Mirsaeidi M, Peyrani P, Aliberti S, Filardo G, Bordon J, Blasi F, Ramirez JA. Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest 2010, 137:416-420. 10.1378/chest.09-0998, 19837825.
16. Laserna E, Sibila O, Aguilar PR, Mortensen EM, Anzueto A, Blanquer JM, Sanz F, Rello J, Marcos PJ, Velez MI, Aziz N, Restrepo MI. Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia. Chest 2012, 142:1193-1199. 10.1378/chest.12-0576, 3494472, 22677348.
17. Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, Tarsia P, Mantero M, Blasi F. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 2012, 54:470-478. 10.1093/cid/cir840, 22109954.
18. Shorr AF, Zilberberg MD, Reichley R, Kan J, Hoban A, Hoffman J, Micek ST, Kollef MH. Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 2012, 54:193-198. 10.1093/cid/cir813, 22109951.
19. Mongardon N, Max A, Bougle A, Pene F, Lemiale V, Charpentier J, Cariou A, Chiche JD, Bedos JP, Mira JP. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study. Crit Care 2012, 16:R155. 10.1186/cc11471, 3580745, 22894879.
20. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, Albrecht V, Limbago B, Talan DA. Prevalence of methicillin-resistant staphylococcus aureus as an etiology of community-acquired pneumonia. Clin Infect Dis 2012, 54:1126-1133. 10.1093/cid/cis022, 22438343.
21. Griffin AT, Peyrani P, Wiemken TL, Ramirez JA, Arnold FW. Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia. Infection 2013, 41:517-523. 10.1007/s15010-012-0363-1, 23132663.
22. Sicot N, Khanafer N, Meyssonnier V, Dumitrescu O, Tristan A, Bes M, Lina G, Vandenesch F, Vanhems P, Etienne J, Gillet Y. Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia-results of a prospective observational study. Clin Microbiol Infect 2013, 19:E142-E148. 10.1111/1469-0691.12022, 23237492.
23. Labarere J, Schuetz P, Renaud B, Claessens YE, Albrich W, Mueller B. Validation of a clinical prediction model for early admission to the intensive care unit of patients with pneumonia. Acad Emerg Med 2012, 19:993-1003. 10.1111/j.1553-2712.2012.01424.x, 22978725.
24. Laupland KB, Zahar JR, Adrie C, Minet C, Vésin A, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Schwebel C, Jamali S, Darmon M, Dumenil AS, Kallel H, Souweine B, Timsit JF Laupland KB, Zahar JR, Adrie C, Minet C, Vésin A, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Schwebel C, Jamali S, Darmon M, Dumenil AS, Kallel H, Souweine B, Timsit JF. Severe hypothermia increases the risk for intensive care unit-acquired infection. Clin Infect Dis 2012, 54:1064-1070. 10.1093/cid/cir1033, 22291110.
25. Perbet S, Mongardon N, Dumas F, Bruel C, Lemiale V, Mourvillier B, Carli P, Varenne O, Mira JP, Wolff M, Cariou A. Early-onset pneumonia after cardiac arrest: characteristics, risk factors and influence on prognosis. Am J Respir Crit Care Med 2011, 184:1048-1054. 10.1164/rccm.201102-0331OC, 21816940.
26. Forel JM, Voillet F, Pulina D, Gacouin A, Perrin G, Barrau K, Jaber S, Arnal JM, Fathallah M, Auquier P, Roch A, Azoulay E, Papazian L. Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy. Crit Care 2012, 16:R65. 10.1186/cc11312, 3681394, 22524447.
27. Klompas M. Complications of mechanical ventilation--the CDC's new surveillance paradigm. N Engl J Med 2013, 368:1472-1475. 10.1056/NEJMp1300633, 23594002.
28. Klompas M, Magill S, Robicsek A, Strymish JM, Kleinman K, Evans RS, Lloyd JF, Khan Y, Yokoe DS, Stevenson K, Samore M, Platt R. CDC Prevention Epicenters Program Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med 2012, 40:3154-3161. 10.1097/CCM.0b013e318260c6d9, 22990454, CDC Prevention Epicenters Program.
29. Hayashi Y, Morisawa K, Klompas M, Jones M, Bandeshe H, Boots R, Lipman J, Paterson DL. Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis 2013, 56:471-477. 10.1093/cid/cis926, 23118272.
30. Metersky ML, Waterer G, Nsa W, Bratzler DW. Predictors of in-hospital vs postdischarge mortality in pneumonia. Chest 2012, 142:476-481. 10.1378/chest.11-2393, 22383662.
31. Carr GE, Yuen TC, McConville JF, Kress JP, VandenHoek TL, Hall JB, Edelson DP. Early cardiac arrest in patients hospitalized with pneumonia: a report from the American Heart Association's Get With The Guidelines-Resuscitation Program. Chest 2012, 141:1528-1536. 10.1378/chest.11-1547, 3367483, 22194592.
32. Benet T, Allaouchiche B, Argaud L, Vanhems P. Impact of surveillance of hospital-acquired infections on the incidence of ventilator-associated pneumonia in intensive care units: a quasi-experimental study. Crit Care 2012, 16:R161. 10.1186/cc11484, 3580751, 22909033.
33. Katsios CM, Burry L, Nelson S, Jivraj T, Lapinsky SE, Wax RS, Christian M, Mehta S, Bell CM, Morris AM. An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients. Crit Care 2012, 16:R216. 10.1186/cc11854, 3672592, 23127353.
34. Avdic E, Cushinotto LA, Hughes AH, Hansen AR, Efird LE, Bartlett JG, Cosgrove SE. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis 2012, 54:1581-1587. 10.1093/cid/cis242, 22495073.
35. Wilson BZ, Anzueto A, Restrepo MI, Pugh MJ, Mortensen EM. Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia. Crit Care Med 2012, 40:2310-2314. 10.1097/CCM.0b013e31825151a8, 22622401.
36. Tseng YT, Chuang YC, Shu CC, Hung CC, Hsu CF, Wang JY. Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia. Crit Care 2012, 16:R207. 10.1186/cc11839, 3682311, 23098258.
37. Fernandez-Serrano S, Dorca J, Garcia-Vidal C, Fernandez-Sabe N, Carratala J, Fernandez-Aguera A, Corominas M, Padrones S, Gudiol F, Manresa F. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care 2011, 15:R96. 10.1186/cc10103, 3219361, 21406101.
38. Polverino E, Cillóniz C, Dambrava P, Gabarrús A, Ferrer M, Agustí C, Prina E, Montull B, Menendez R, Niederman MS, Torres A. Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome. Respirology 2013, 18:263-271. 10.1111/resp.12013, 23134361.
39. Remmelts HH, Meijvis SC, Heijligenberg R, Rijkers GT, Oosterheert JJ, Bos WJ, Endeman H, Grutters JC, Hoepelman AI, Biesma DH. Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia. J Infect 2012, 65:25-31. 10.1016/j.jinf.2012.03.008, 22410382.
40. Kim JW, Chung J, Choi SH, Jang HJ, Hong SB, Lim CM, Koh Y. Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial. Crit Care 2012, 16:R28. 10.1186/cc11197, 3396273, 22336530.
41. Kollef MH, Chastre J, Clavel M, Restrepo MI, Michiels B, Kaniga K, Cirillo I, Kimko H, Redman R. A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Crit Care 2012, 16:R218. 10.1186/cc11862, 3672596, 23148736.
42. Chytra I, Stepan M, Benes J, Pelnar P, Zidkova A, Bergerova T, Pradl R, Kasal E. Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial. Crit Care 2012, 16:R113. 10.1186/cc11405, 3580671, 22742765.
43. Wunderink RG, Cammarata SK, Oliphant TH, Kollef MH. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther 2003, 25:980-992. 10.1016/S0149-2918(03)80118-2, 12852712.
44. Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 2012, 54:621-629. 10.1093/cid/cir895, 22247123.
45. Kumar A, Zarychanski R, Light B, Parrillo J, Maki D, Simon D, Laporta D, Lapinsky S, Ellis P, Mirzanejad Y, Martinka G, Keenan S, Wood G, Arabi Y, Feinstein D, Kumar A, Dodek P, Kravetsky L, Doucette S. Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med 2010, 38:1773-1785. 10.1097/CCM.0b013e3181eb3ccd, 20639750, Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group.
46. Diaz-Martin A, Martinez-Gonzalez ML, Ferrer R, Ortiz-Leyba C, Piacentini E, Lopez-Pueyo MJ, Martin-Loeches I, Levy MM, Artigas A, Garnacho-Montero J. Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality. Crit Care 2012, 16:R223. 10.1186/cc11869, 3672602, 23158399.
47. Choi SH, Hong SB, Ko GB, Lee Y, Park HJ, Park SY, Moon SM, Cho OH, Park KH, Chong YP, Kim SH, Huh JW, Sung H, Do KH, Lee SO, Kim MN, Jeong JY, Lim CM, Kim YS, Woo JH, Koh Y. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 2012, 186:325-332. 10.1164/rccm.201112-2240OC, 22700859.
48. Giannella M, Rodriguez-Sanchez B, Roa PL, Catalan P, Munoz P, de Viedma DG, Bouza E. Should lower respiratory tract secretions from intensive care patients be systematically screened for influenza virus during the influenza season?. Crit Care 2012, 16:R104. 10.1186/cc11387, 3580661, 22697813.
49. Ylipalosaari P, Ala-Kokko TI, Karhu J, Koskela M, Laurila J, Ohtonen P, Syrjala H. Comparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment. Crit Care 2012, 16:R62. 10.1186/cc11307, 3681391, 22512852.
50. Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, Dimopoulos G, Paiva JA, Misset B, Rello J, Vandewoude K, Vogelaers D, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, Dimopoulos G, Paiva JA, Misset B, Rello J, Vandewoude K, Vogelaers D. AspICU Study Investigators Blot SI, AspICU Study Investigators A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med 2012, 186:56-64. 10.1164/rccm.201111-1978OC, 22517788, AspICU Study Investigators Blot SI, AspICU Study Investigators.
51. Labeau SO, Van de Vyver K, Brusselaers N, Vogelaers D, Blot SI. Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis. Lancet Infect Dis 2011, 11:845-854. 10.1016/S1473-3099(11)70127-X, 21798809.
52. Gu WJ, Gong YZ, Pan L, Ni YX, Liu JC. Impact of oral care with versus without toothbrushing on the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. Crit Care 2012, 16:R190. 10.1186/cc11675, 3682292, 23062250.
53. van Delden C, Kohler T, Brunner-Ferber F, Francois B, Carlet J, Pechere JC. Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: a randomized controlled trial. Intensive Care Med 2012, 38:1118-1125. 10.1007/s00134-012-2559-3, 22527075.
54. Arvaniti K, Lathyris D, Ruimy R, Haidich AB, Koulourida V, Nikolaidis P, Matamis D, Miyakis S. The importance of colonization pressure in multiresistant Acinetobacter baumannii acquisition in a Greek intensive care unit. Crit Care 2012, 16:R102. 10.1186/cc11383, 3580657, 22694969.